AngioDynamics
ANGO
154 hedge funds and large institutions have $259M invested in AngioDynamics in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 44 reducing their positions, and 28 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 44
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
1% less funds holding
Funds holding: 156 → 154 (-2)
2.47% less ownership
Funds ownership: 91.68% → 89.21% (-2.5%)
31% less capital invested
Capital invested by funds: $376M → $259M (-$117M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$11.2M |
| 2 |
Morgan Stanley
New York
|
+$8.47M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$5.36M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.05M |
| 5 |
Two Sigma Advisers
New York
|
+$3.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$26.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$15M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$8.02M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$7.44M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.93M |
ANGO Hedge Fund Activity: Q3 2023 in Review
154 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2023, worth a combined $259M — down 31% from $376M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ANGO and 27 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 69 added.
The largest buyer was Millennium Management, adding an estimated $11.2M. The largest seller was BlackRock, cutting an estimated $26.8M.
- 154 institutional investors held AngioDynamics (ANGO) as of Q3 2023, down from 156 in Q2 2023.
- Funds reported $259M of AngioDynamics stock for Q3 2023, down 31% quarter-over-quarter.
- 27 funds opened new AngioDynamics positions in Q3 2023 and 28 closed out, a net change of -1 holder.
- The largest AngioDynamics buyer in Q3 2023 was Millennium Management, an estimated $11.2M added.
- The largest AngioDynamics seller in Q3 2023 was BlackRock, an estimated $26.8M sold.
Based on aggregated 13F filings for Q3 2023.